Anti-Müllerian hormone in breast cancer patients treated with chemotherapy: a retrospective evaluation of subsequent pregnancies  Anne-Sophie Hamy, Raphaël.

Slides:



Advertisements
Similar presentations
Attitudes and policies regarding access to fertility care and assisted reproductive technologies in Israel  Daniel Sperling, Yael Simon  Reproductive.
Advertisements

Vuong Thi Ngoc Lan, Nguyen Khanh Linh, Ho Manh Tuong, P. C
M. Leyder, M. De Vos, B. Popovic-Todorovic, M. Dujardin, P. Devroey, H
Fresh and cryopreserved ovary transplantation and resting follicle recruitment  Sherman Silber, Jorge Pineda, Kathleen Lenahan, Michael DeRosa, Jeffrey.
Norbert Gleicher, Andrea Weghofer, David H. Barad 
Protective effect of resveratrol against oxidative damage to ovarian reserve in female Sprague–Dawley rats  Pınar Özcan, Cem Fıçıcıoğlu, Özge Kızılkale.
Complete surgical removal of minimal and mild endometriosis improves outcome of subsequent IVF/ICSI treatment  H.K. Opøien, P. Fedorcsak, T. Åbyholm,
Luteal phase HCG support for unexplained recurrent pregnancy loss – a low hanging fruit?  Chelsea Fox, Denise Azores-Gococo, Linda Swart, Kristin Holoch,
S.M. Nelson, A. La Marca  Reproductive BioMedicine Online 
External validation of nomogram for the decline in serum anti-Müllerian hormone in women: a population study of 15,834 infertility patients  Scott M.
Mid-luteal progesterone concentrations are associated with live birth rates during ovulation induction  J.-C. Arce, A. Balen, P. Platteau, G. Pettersson,
E. Jauniaux, I. Ben-Ami, R. Maymon  Reproductive BioMedicine Online 
Preovulatory progesterone concentration associates significantly to follicle number and LH concentration but not to pregnancy rate  Claus Yding Andersen,
Ovarian response markers lead to appropriate and effective use of corifollitropin alpha in assisted reproduction  Antonio La Marca, Giovanni D’Ippolito 
Advanced glycation end product concentrations in follicular fluid of women undergoing IVF/ICSI with a GnRH agonist protocol  Qi Yao, Yuanjiao Liang, Yong.
Intra-cycle fluctuations of anti-Müllerian hormone in normal women with a regular cycle: a re-analysis  Annelies Overbeek, Frank J. Broekmans, Wouter.
E. Jauniaux, I. Ben-Ami, R. Maymon  Reproductive BioMedicine Online 
Willem Ombelet  Reproductive BioMedicine Online 
A. La Marca, G. Sighinolfi, S. Giulini, M. Traglia, C. Argento, C
High serum oestradiol concentrations in IVF cycles increase the risk of pregnancy complications related to abnormal placentation  Jacob Farhi, Avi Ben.
Fresh transfer outcome predicts the success of a subsequent frozen transfer utilizing blastocysts of the same cohort  L.F. Doherty, J.R. Martin, U. Kayisli,
Gillian M. Lockwood  Reproductive BioMedicine Online 
Establishment and validation of a score to predict ovarian response to stimulation in IVF  Clelia Chalumeau, Jessika Moreau, Nicolas Gatimel, Clementine.
Anti-Müllerian hormone as a predictor of pregnancy following IVF
Anti-Müllerian hormone as an independent predictor of twin versus singleton pregnancy in fresh cycles  Reshef Tal, David B. Seifer, Moisey Khanimov, Eliana.
Sherman Silber  Reproductive BioMedicine Online 
Why are reproductive cancers more common in nulliparous women?
Moniek van der Zanden, Annemiek W. Nap  Reproductive BioMedicine Online 
Utility of age-specific serum anti-Müllerian hormone concentrations
What’s on the mind of IVF consumers?
S Munné, E Fragouli, P Colls, MG Katz-Jaffe, WB Schoolcraft, D Wells 
Sarah McCredie, William Ledger, Christos A. Venetis 
Effect of N-acetyl-cysteine after ovarian drilling in clomiphene citrate-resistant PCOS women: a pilot study  A. Nasr  Reproductive BioMedicine Online 
Fertility preservation consultation for women with cancer: are we helping patients make high-quality decisions?  Jayeon Kim, Allison M. Deal, Ursula Balthazar,
Effect of energy expenditure and physical activity on the outcomes of assisted reproduction treatment  Mert Kucuk, Fadime Doymaz, Bulent Urman  Reproductive.
M. Dieterich, M. Bolz, T. Reimer, S. Costagliola, B. Gerber 
Ovarian reserve in breast cancer: assessment with anti-Müllerian hormone  Anne-Sophie Hamy, Raphaël Porcher, Caroline Cuvier, Sylvie Giacchetti, Marie-Hélène.
Male age negatively influences clinical pregnancy rate in women younger than 40 years undergoing donor insemination cycles  Su-Ann Koh, Katherine Sanders,
Anne ter Keurst, Jacky Boivin, Sofia Gameiro 
Donor information considered important to donors, recipients and offspring: an Australian perspective  I.S. Rodino, P.J. Burton, K.A. Sanders  Reproductive.
Dehydroepiandrostendione sulphate and prediction of live birth after IVF in young women with low anti-Müllerian hormone concentration  Miro Šimun Alebić,
A retrospective analysis of ovarian stimulation with letrozole in women undergoing artificial insemination by donor  X.J. Sun, L. Jiang, L.C. Ji, R. Nie,
Mid-follicular LH supplementation in women aged 35–39 years undergoing ICSI cycles: a randomized controlled study  R Matorras, B Prieto, A Exposito, R.
A unique biological in-vivo model to evaluate follicular development during in-vitro maturation treatment  S.E. Elizur, W.Y. Son, H. Clarke, D. Morris,
Influence of adjuvant chemotherapy on anti-Müllerian hormone in women below 35 years treated for early breast cancer  Anne Perdrix, Mathilde Saint-Ghislain,
Cumulative delivery rates after ICSI with donor spermatozoa in different age groups  Michaël De Brucker, Michel Camus, Patrick Haentjens, Jacques Francotte,
Serum anti-carbonic anhydrase I and II antibodies and idiopathic recurrent pregnancy loss  S Caner Karahan, Suleyman Guven, Ahmet Mentese, Aynur Bacak,
The value of HCG serum concentrations after trigger in predicting pregnancy and live birth rates in IVF–ICSI  Jianjun Zhou, Shanshan Wang, Bin Wang, Junxia.
LH concentrations do not correlate with pregnancy in rFSH/GnRH antagonist cycles  Kevin Doody, Paul Devroey, Keith Gordon, Han Witjes, Bernadette Mannaerts 
A clinically useful simplified blastocyst grading system
Sarah Nordqvist, Karin Kårehed, Anneli Stavreus-Evers, Helena Åkerud 
Assessment of endometrial and subendometrial blood flow in women undergoing frozen embryo transfer cycles  Anupa Nandi, Wellington P. Martins, Kannamannadiar.
Should we be promoting embryo transfer at blastocyst stage?
Stephen C. Collins, Esther Chan  Reproductive BioMedicine Online 
Pietro Gambadauro, Ramesan Navaratnarajah 
Serum inhibin A concentration in women with polycystic ovarian syndrome and the correlation to ethnicity, androgens and insulin resistance  Shimon Segal,
Does exogenous LH in ovarian stimulation improve assisted reproduction success? An appraisal of the literature  Micah J. Hill, Gary Levy, Eric D. Levens 
Jeff G. Wang, Nataki C. Douglas, Gary S. Nakhuda, Janet M
The Alpha Consensus Meeting on the professional status of the clinical embryologist: proceedings of an expert meeting    Reproductive BioMedicine Online 
Response: time-lapse systems for ART
Testosterone concentrations in early pregnancy: relation to method of conception in an infertile population  Ruth B. Lathi, Sharon E. Moayeri, Charitha.
Aryl hydrocarbon receptor antagonists attenuate the deleterious effects of benzo[a]pyrene on isolated rat follicle development  Michael S. Neal, Anne.
Progesterone elevation on the day of HCG administration may affect rescue ICSI  Bo Huang, Zhou Li, Lixia Zhu, Dan Hu, Qun Liu, Guijin Zhu, Hanwang Zhang 
Predictive value of ovarian reserve markers in smoking and non-smoking women undergoing IVF  Thomas Freour, Lionel Dessolle, Miguel Jean, Damien Masson,
Ovarian reserve screening before contraception?
The significance of the number of CGG repeats and autoantibodies in premature ovarian failure  Cem Fıçıcıoglu, Gazi Yildirim, Rukset Attar, Banu Kumbak,
John Yovich, James Stanger, Peter Hinchliffe 
China’s model of egg donation is a policy lesson for Britain
M. Franz, J. Ott, A. Watrelot, L. Küssel, H. Husslein 
Fertility in cancer patients after cryopreservation of one ovary
Presentation transcript:

Anti-Müllerian hormone in breast cancer patients treated with chemotherapy: a retrospective evaluation of subsequent pregnancies  Anne-Sophie Hamy, Raphaël Porcher, Sarah Eskenazi, Caroline Cuvier, Sylvie Giacchetti, Florence Coussy, Hamid Hocini, Bertrand Tournant, Francine Perret, Sylvie Bonfils, Patrick Charvériat, Jean-Marc Lacorte, Marc Espie  Reproductive BioMedicine Online  Volume 32, Issue 3, Pages 299-307 (March 2016) DOI: 10.1016/j.rbmo.2015.12.008 Copyright © 2015 Reproductive Healthcare Ltd. Terms and Conditions

Figure 1 Serum anti-Müllerian hormone (AMH) concentrations in women with subsequent pregnancy. The blue points represent AMH assays (log scale, ng/ml) as a function of time since last chemotherapy (years). The horizontal grey line shows the limit of detection of AMH according to the manufacturer (0.14 ng/ml). The black arrows represent the beginning of each pregnancy. Reproductive BioMedicine Online 2016 32, 299-307DOI: (10.1016/j.rbmo.2015.12.008) Copyright © 2015 Reproductive Healthcare Ltd. Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.